My introduction to the new neurologist was rather disappointing. Apart from the fact that he did not even make any attempt to come across as somewhat understanding and social, this person again lacked constructive thinking about possible improvements to the PD and PN (peripheral neuropathy) situation. Each time, however, extensive testing is done so that after 6 months we can ascertain to what extent further deterioration has occurred and medication needs to be adjusted (increased). Which means we are always chasing after the facts...... In vain I try to read the neurologist's mind and during the examination I force some speaking time by asking questions. That is then responded with a tired look, but there is the courtesy of answering. Now I am pretty well informed by you, but HU could not yet give me a satisfactory answer on the consideration in my special situation for a C/L medication with more or less carbidopa. But luckily you have a neurologist for that! Probably because of my, like my English, poor French, he explained it even with a little drawing. There was no difference between Sinemet 10/100 and 25/100 IR. It was about the amount of levodopa. The carbidopa was only added because of possible nausea and stomach upset. Well, then you are speechless, whatever language you speak.
So again the call about the C/L medication, who has the Pharmacokinetics, pharmacodynamics of both 10/100 IR and 25/100 IR (immediat release).
MERCI 🍀